Gonorrhea – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033


 

Neisseria gonorrhea is an obligate human pathogen primarily transmitted through sexual contact. It infects humans exclusively and commonly causes urethritis in men and cervicitis in women. As an obligate pathogen, N. gonorrhea relies on manifesting disease to facilitate transmission between hosts. It cannot survive outside of a host and must infect a host. The infection process of N. gonorrhea begins with the adherence of gonococci to epithelial cells, followed by local invasion of these cells. Adhesion is facilitated by multiple surface proteins, including pili, hair-like appendages covering the bacterial surface. Pili allow the bacteria to attach to epithelial cells from a distance and promote cellular invasion. Additionally, pili provide motility and protection to the bacteria. Other surface proteins involved in cellular attachment include Opa (opacity-associated proteins) and LOS (lipooligosaccharide), which can attach to sperm cells and potentially contribute to transmission from infected males to uninfected sexual partners. Symptoms of gonorrhea may include green or yellow discharge from the penis, pain or burning sensation during urination, discomfort and swelling of the testicles (in men), increased vaginal discharge, lower abdominal pain (particularly during sex), and bleeding between periods or after sex. In routine settings, the diagnosis of gonorrhea can be verified quickly through direct microscopy of urethral or cervical smears stained with Gram or methylene blue. Gram staining is more specific than methylene blue staining. Risk factors for N. gonorrhea infection include sexual contact with new or multiple partners, sexual contact with individuals who have concurrent partners or current N. gonorrhea infection, inconsistent condom use with nonmonogamous partners, previous history of N. gonorrhea infection, and engaging in sex for money, drugs, or other items. Gonorrhea has increased over the past 20 years due to antimicrobial resistance. If gonorrhea infections are not detected or appropriately treated, they can lead to serious reproductive health complications in women, such as pelvic inflammatory disease, chronic pelvic pain, infertility, first-trimester abortion, and ectopic pregnancy.

  • In the USA, the highest reported cases of gonorrhea were observed in women aged 20 to 24 years (866.9 per 100,000), followed by those aged 15 to 19 years (616.4 per 100,000) and 25 to 29 years (505.3 per 100,000). Among men, the highest reported cases were found in those aged 20 to 24 years (821.5 per 100,000), followed by those aged 25 to 29 years (727.9 per 100,000) and 30 to 34 years (567.6 per 100,000).

Thelansis’s “Gonorrhea Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Gonorrhea treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

KOLs insights of Gonorrhea across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs.

Gonorrhea Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model, Market uptake and patient share uptake, Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario, Summary, and Insights.

Thelansis Competitive Intelligence (CI) practice has been established based on a deep understanding of the pharma/biotech business environment to provide an optimized support system to all levels of the decision-making process. It enables business leaders in forward-thinking and proactive decision-making. Thelansis supports scientific and commercial teams in seamless CI support by creating an AI/ ML-based technology-driven platform that manages the data flow from primary and secondary sources.

Read more: Gonorrhea – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Comments

Post a Comment

Popular posts from this blog

Acne Vulgaris – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032

Image
  Acne vulgaris, a prevalent pilosebaceous unit inflammatory skin disorder, follows a persistent course. Typically presenting as papules, pustules, or nodules, it primarily occurs on the face but can also impact the upper arms, trunk, and back. The development of acne results from the sebaceous glands' heightened sensitivity to normal androgen levels, aggravated by Cutibacterium acnes (formerly known as Propionibacterium acnes), a bacterial species that triggers inflammation. The pathogenesis of acne vulgaris involves a complex interplay of factors such as the activation of sebaceous glands by androgens, imbalances in the pilosebaceous follicle microbiome, and cellular immune responses. Genetic predisposition and dietary influences also contribute to the condition's onset and progression. The initial stage is the micro-comedo, a small plug primarily composed of corneocytes in the lower follicular infundibulum. Microcomedones evolve into various acne lesions, including closed co...
Read more

Herpes Simplex Virus (HSV) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
 Herpes simplex virus (HSV) causes an infection that affects the external genitalia, anal region, mucosal surfaces, and skin in other body parts. Herpes simplex virus is a ubiquitous, host-adapted pathogen that causes various disease states. There are two types of HSV with two distinct DNA viruses, type 1 (HSV-1) and type 2 (HSV-2). Both the types are closely related but differ epidemiologically. HSV-1 is traditionally associated with orofacial disease by affecting the mouth and lips with fever blisters and cold sores, whereas HSV-2 is associated traditionally with genital disease infecting genitals and rectum area with sores and is classified as STD (sexually transmitted disease). As HSV-1 is associated with genital infections more often than HSV-2, lesion location is not necessarily of viral type. HSV can spread through direct contact. Almost 80% of Herpes simplex infections are asymptomatic, while symptomatic infections can be characterized by significant morbidity and recurrenc...
Read more

HR+/HER2- Breast Cancer – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
Thelansis’s “HR+/HER2- Breast Cancer Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential HR+/HER2- Breast Cancer treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). KOLs insights of HR+/HER2- Breast Cancer across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs. HR+/HER2- Breast Cancer Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model,...
Read more